200 related articles for article (PubMed ID: 25119502)
1. EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.
Li H; Zhang B; Liu Y; Yin C
Med Oncol; 2014 Sep; 31(9):162. PubMed ID: 25119502
[TBL] [Abstract][Full Text] [Related]
2. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
3. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells.
Jeong YJ; Choi Y; Shin JM; Cho HJ; Kang JH; Park KK; Choe JY; Bae YS; Han SM; Kim CH; Chang HW; Chang YC
Food Chem Toxicol; 2014 Jun; 68():218-25. PubMed ID: 24675423
[TBL] [Abstract][Full Text] [Related]
4. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
Zheng J; Dai Y; Yang Z; Yang L; Peng Z; Meng R; Xiong Y; He J
Oncol Rep; 2016 Jan; 35(1):530-7. PubMed ID: 26531778
[TBL] [Abstract][Full Text] [Related]
5. EBP50 phosphorylation by Cdc2/Cyclin B kinase affects actin cytoskeleton reorganization and regulates functions of human breast cancer cell line MDA-MB-231.
Sun C; Zheng J; Cheng S; Feng D; He J
Mol Cells; 2013 Jul; 36(1):47-54. PubMed ID: 23775624
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) by Akt promotes stability and mitogenic function of S-phase kinase-associated protein-2 (Skp2).
Song GJ; Leslie KL; Barrick S; Mamonova T; Fitzpatrick JM; Drombosky KW; Peyser N; Wang B; Pellegrini M; Bauer PM; Friedman PA; Mierke DF; Bisello A
J Biol Chem; 2015 Jan; 290(5):2879-87. PubMed ID: 25492869
[TBL] [Abstract][Full Text] [Related]
7. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
[TBL] [Abstract][Full Text] [Related]
8. NCAM regulates the proliferation, apoptosis, autophagy, EMT, and migration of human melanoma cells via the Src/Akt/mTOR/cofilin signaling pathway.
Li J; Yang R; Yang H; Chen S; Wang L; Li M; Yang S; Feng Z; Bi J
J Cell Biochem; 2020 Feb; 121(2):1192-1204. PubMed ID: 31468584
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadherin pathway in human hepatocellular cancer.
Peng XL; Ji MY; Yang ZR; Song J; Dong WG
World J Gastroenterol; 2013 Feb; 19(8):1306-13. PubMed ID: 23483729
[TBL] [Abstract][Full Text] [Related]
10. NHERF1: molecular brake on the PI3K pathway in breast cancer.
Georgescu MM
Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
[TBL] [Abstract][Full Text] [Related]
11. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
Bi QJ; Men XJ; Han R; Li GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
[TBL] [Abstract][Full Text] [Related]
12. EBP50 suppresses the proliferation of MCF-7 human breast cancer cells via promoting Beclin-1/p62-mediated lysosomal degradation of c-Myc.
Liu H; Zhao WL; Wang JP; Xin BM; Shao RG
Acta Pharmacol Sin; 2018 Aug; 39(8):1347-1358. PubMed ID: 29283175
[TBL] [Abstract][Full Text] [Related]
13. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
14. Ezrin-Radixin-Moesin Binding Phosphoprotein 50 (EBP50) Suppresses the Metastasis of Breast Cancer and HeLa Cells by Inhibiting Matrix Metalloproteinase-2 Activity.
Wang L; Qi Y; Xiong Y; Peng Z; Ma Q; Zhang Y; Song J; Zheng J
Anticancer Res; 2017 Aug; 37(8):4353-4360. PubMed ID: 28739728
[TBL] [Abstract][Full Text] [Related]
15. Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate.
Li JG; Chen C; Liu-Chen LY
J Biol Chem; 2002 Jul; 277(30):27545-52. PubMed ID: 12004055
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells.
Liu Y; Wang J; Wu M; Wan W; Sun R; Yang D; Sun X; Ma D; Ying G; Zhang N
Mol Cancer Res; 2009 Jun; 7(6):944-54. PubMed ID: 19531564
[TBL] [Abstract][Full Text] [Related]
17. kappa Opioid receptor interacts with Na(+)/H(+)-exchanger regulatory factor-1/Ezrin-radixin-moesin-binding phosphoprotein-50 (NHERF-1/EBP50) to stimulate Na(+)/H(+) exchange independent of G(i)/G(o) proteins.
Huang P; Steplock D; Weinman EJ; Hall RA; Ding Z; Li J; Wang Y; Liu-Chen LY
J Biol Chem; 2004 Jun; 279(24):25002-9. PubMed ID: 15070904
[TBL] [Abstract][Full Text] [Related]
18. A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.
Wang S; Zhang Y; Ren T; Wu Q; Lu H; Qin X; Liu Y; Ding H; Zhao Q
Cell Death Dis; 2020 Jun; 11(6):491. PubMed ID: 32606352
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G
BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485
[TBL] [Abstract][Full Text] [Related]
20. The mitotic kinase Aurora-A induces mammary cell migration and breast cancer metastasis by activating the Cofilin-F-actin pathway.
Wang LH; Xiang J; Yan M; Zhang Y; Zhao Y; Yue CF; Xu J; Zheng FM; Chen JN; Kang Z; Chen TS; Xing D; Liu Q
Cancer Res; 2010 Nov; 70(22):9118-28. PubMed ID: 21045147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
